High frequency of BRCA1 5382insC mutation in Russian breast cancer patients

European Journal of Cancer

Volumn 42, Issue 10, 2006, Pages 1380-1384

  Sokolenko, Anna P ^a   Mitiushkina, Natalia V ^a   Buslov, Konstantin G ^a   Bit Sava, Elena M ^a   Iyevleva, Aglaya G ^a   Chekmariova, Elena V ^a   Kuligina, Ekatherina Sh ^a   Ulibina, Yulia M ^a   Rozanov, Maxim E ^a   Suspitsin, Evgeny N ^a   Matsko, Dmitry E ^a   Chagunava, Oleg L ^b   Trofimov, Dmitry Yu ^c   Devilee, Peter ^d   Cornelisse, Cees ^d   Togo, Alexandr V ^a   Semiglazov, Vladimir F ^a   Imyanitov, Evgeny N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b Center of Mammology   (Russian Federation)

^c DNA Technology JSC   (Russian Federation)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1; Breast cancer; Founder mutation; Susceptibility

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; BREAST TUMOR; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; HUNGARY; MAJOR CLINICAL STUDY; ONCOGENE; OVARY TUMOR; PRIORITY JOURNAL; RUSSIAN FEDERATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; GENE FREQUENCY; GENES, BRCA1; HUMANS; MIDDLE AGED; MUTATION; RUSSIA;

EID: 33745144366     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.01.050     Document Type: Article

References (25)

1. Nathanson K.L., Wooster R., and Weber B.L. Breast cancer genetics: what we know and what we need. Nat Med 7 (2001) 552-556
2. Imyanitov E.N., and Hanson K.P. Mechanisms of breast cancer. Drug Discov Today Dis Mech 1 (2004) 235-245
3. Narod S.A., and Foulkes W.D. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4 (2004) 665-676
4. Neuhausen S.L. Founder populations and their uses for breast cancer genetics. Breast Cancer Res 2 (2000) 77-81
5. Phelan C.M., Kwan E., Jack E., et al. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Hum Mutat 20 (2002) 352-357
6. Gorski B., Jakubowska A., Huzarski T., et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110 (2004) 683-686
7. Szabo C.I., and King M.C. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60 (1997) 1013-1020
8. Backe J., Hofferbert S., Skawran B., et al. Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol Oncol 72 (1999) 402-406
9. Gayther S.A., Harrington P., Russell P., Kharkevich G., Garkavtseva R.F., and Ponder B.A. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet 60 (1997) 1239-1242
10. Tereschenko I.V., Basham V.M., Ponder B.A., and Pharoah P.D. BRCA1 and BRCA2 mutations in Russian familial breast cancer. Hum Mutat 19 (2002) 184
11. Loginova A.N., Pospekhova N.I., Lyubchenko L.N., et al. Spectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families. Bull Exp Biol Med 136 (2003) 276-278
12. Buslov K.G., Iyevleva A.G., Chekmariova E.V., et al. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int J Cancer 114 (2005) 585-589
13. Hiratsuka M., Agatsuma Y., and Mizugaki M. Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green. Mol Genet Metab 68 (1999) 357-362
14. Struewing J.P., Hartge P., Wacholder S., et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336 (1997) 1401-1408
15. Fodor F.H., Weston A., Bleiweiss I.J., et al. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet 63 (1998) 45-51
16. Warner E., Foulkes W., Goodwin P., et al. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91 (1999) 1241-1247
17. Bahar A.Y., Taylor P.J., Andrews L., et al. The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data. Cancer 92 (2001) 440-445
18. Satagopan J.M., Offit K., Foulkes W., et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 10 (2001) 467-473
19. King M.C., Marks J.H., and Mandell J.B. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302 (2003) 643-646
20. McClain M.R., Nathanson K.L., Palomaki G.E., and Haddow J.E. An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women. Genet Med 7 (2005) 34-39
21. Gorski B., Cybulski C., Huzarski T., et al. Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92 (2005) 19-24
22. Gershoni-Baruch R., Dagan E., Fried G., Kepten I., and Robinson E. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer. Eur J Hum Genet 7 (1999) 833-836
23. Roa B.B., Boyd A.A., Volcik K., and Richards C.S. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14 (1996) 185-187
24. Imyanitov E.N., Togo A.V., and Hanson K.P. Searching for cancer-associated gene polymorphisms: promises and obstacles. Cancer Lett 204 (2004) 3-14
25. Jakubowska A., Narod S.A., Goldgar D.E., et al. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol Biomarkers Prev 12 (2003) 457-459